HK1244432A1 - 組合物 - Google Patents

組合物

Info

Publication number
HK1244432A1
HK1244432A1 HK18103847.9A HK18103847A HK1244432A1 HK 1244432 A1 HK1244432 A1 HK 1244432A1 HK 18103847 A HK18103847 A HK 18103847A HK 1244432 A1 HK1244432 A1 HK 1244432A1
Authority
HK
Hong Kong
Prior art keywords
composition
Prior art date
Application number
HK18103847.9A
Other languages
English (en)
Inventor
Howard Norman Ernest Stevens
Alexander Balfour Mullen
David Smith
Fiona Jane Macdougall
Vivekanand Bhardwaj
Original Assignee
Drug Delivery Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drug Delivery Int Ltd filed Critical Drug Delivery Int Ltd
Publication of HK1244432A1 publication Critical patent/HK1244432A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/288—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK18103847.9A 2014-11-14 2018-03-20 組合物 HK1244432A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1420306.1A GB201420306D0 (en) 2014-11-14 2014-11-14 Compositions
PCT/GB2015/053471 WO2016075495A1 (en) 2014-11-14 2015-11-16 Composition

Publications (1)

Publication Number Publication Date
HK1244432A1 true HK1244432A1 (zh) 2018-08-10

Family

ID=52248394

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18103847.9A HK1244432A1 (zh) 2014-11-14 2018-03-20 組合物

Country Status (19)

Country Link
US (1) US10675247B2 (zh)
EP (1) EP3217964B1 (zh)
JP (1) JP6774103B2 (zh)
KR (1) KR102253728B1 (zh)
CN (1) CN106999438A (zh)
AU (1) AU2015344838B2 (zh)
CA (1) CA2967738C (zh)
DK (1) DK3217964T3 (zh)
ES (1) ES2755960T3 (zh)
GB (1) GB201420306D0 (zh)
HK (1) HK1244432A1 (zh)
HU (1) HUE047581T2 (zh)
MX (1) MX2017006168A (zh)
PL (1) PL3217964T3 (zh)
PT (1) PT3217964T (zh)
RU (1) RU2717574C2 (zh)
SA (1) SA517381522B1 (zh)
SI (1) SI3217964T1 (zh)
WO (1) WO2016075495A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201420311D0 (en) * 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Pharmaceutical processing
US11571391B2 (en) * 2018-01-09 2023-02-07 Triastek, Inc. Oral drug dosage forms compromising a fixed-dose of an ADHD non-stimulant and an ADHD stimulant
WO2023214280A1 (en) * 2022-05-06 2023-11-09 Craft Health Pte Ltd System for controllable release in 3d-printed colon targeting (corr3ct) oral dosage form

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132753A (en) 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
JPS5839618A (ja) 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
US4443428A (en) 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
US5026560A (en) 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US5126145A (en) 1989-04-13 1992-06-30 Upsher Smith Laboratories Inc Controlled release tablet containing water soluble medicament
EP0418596A3 (en) 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
IE61651B1 (en) 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
WO1993019741A1 (en) * 1992-03-31 1993-10-14 Benzon Pharma A/S A pharmaceutical formulation
JP3059004B2 (ja) * 1992-09-18 2000-07-04 ダイセル化学工業株式会社 アルカリ水溶液に対する溶解性の高い低置換度ヒドロキシプロピルセルロース及びその製造法
IL109770A0 (en) 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
US5690959A (en) 1993-05-29 1997-11-25 Smithkline Beecham Corporation Pharmaceutical thermal infusion process
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
JPH07223970A (ja) * 1994-02-10 1995-08-22 Tanabe Seiyaku Co Ltd 消化管内適所放出製剤
EP1121103B1 (en) 1998-05-18 2006-12-20 Takeda Pharmaceutical Company Limited Orally disintegrable tablets comprising a benzimidazole
IL142896A0 (en) 1998-11-02 2002-04-21 Elan Corp Plc Multiparticulate modified release composition
US6340478B1 (en) 1999-06-07 2002-01-22 Bio Dar Ltd. Microencapsulated and controlled-release herbal formulations
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
WO2001019349A2 (en) 1999-09-10 2001-03-22 Ranbaxy Laboratories Limited Extended release formulation of etodolac
IN190974B (zh) * 1999-09-10 2003-09-06 Ranbaxy Lab Ltd
RU2230556C2 (ru) 1999-10-29 2004-06-20 Эро-Селтик, С.А. Препаративные формы гидрокодона с контролируемым высвобождением
KR100574213B1 (ko) 2000-01-27 2006-04-27 다나베 세이야꾸 가부시키가이샤 서방성 제제 및 그의 제조 방법
JP4817562B2 (ja) * 2001-09-26 2011-11-16 東和薬品株式会社 長時間持続型ニフエジピン有核錠
JP2003171277A (ja) * 2001-12-07 2003-06-17 Wyeth Lederle Japan Ltd 薬物放出時間制御型固形製剤
AU2004231362B2 (en) 2003-04-24 2009-11-12 Jagotec Ag Delayed release tablet with defined core geometry
US20040241234A1 (en) * 2003-06-02 2004-12-02 Alpharma, Inc. Controlled release press-coated formulations of water-soluble active agents
US6869963B2 (en) * 2003-07-11 2005-03-22 Sandoz Ag Stable pharmaceutical compositions containing an ACE inhibitor
WO2005041935A1 (en) 2003-10-21 2005-05-12 Alpharma, Inc. Pharmaceutical formulations containing quetiapine
EP1715856B1 (en) 2003-12-31 2012-07-11 Actavis Group PTC ehf. Atomoxetine formulations
US20050220877A1 (en) * 2004-03-31 2005-10-06 Patel Ashish A Bilayer tablet comprising an antihistamine and a decongestant
US20060008527A1 (en) 2004-07-09 2006-01-12 Yury Lagoviyer Controlled phase composition technology as an improved process for protection of drugs
WO2006035313A1 (en) 2004-09-29 2006-04-06 Aurobindo Pharma Ltd Solid unit dosage forms of 5-ht1 agonist
US20070129402A1 (en) 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
ZA200802602B (en) 2005-08-24 2009-10-28 Rubicon Res Pvt Ltd Controlled release formulation
NZ573173A (en) * 2006-06-01 2012-03-30 Msd Consumer Care Inc Phenylephrine pharmaceutical formulation and compositions for colonic absorption
KR100812538B1 (ko) 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제
US9833510B2 (en) 2007-06-12 2017-12-05 Johnson & Johnson Consumer Inc. Modified release solid or semi-solid dosage forms
EP2214651A1 (en) * 2007-10-25 2010-08-11 Bayer Yakuhin, Ltd. Nifedipine-containing press coated tablet and method of preparing the same
JP4329947B1 (ja) * 2009-01-20 2009-09-09 ライオン株式会社 内服用錠剤
GB201003734D0 (en) * 2010-03-05 2010-04-21 Univ Strathclyde Delayed prolonged drug delivery
GB201003766D0 (en) * 2010-03-05 2010-04-21 Univ Strathclyde Pulsatile drug release
GB201003731D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Immediate/delayed drug delivery
CN103690545A (zh) 2013-11-27 2014-04-02 河南中帅医药科技股份有限公司 口服***择时释放制剂及其制备方法
GB201420300D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Tablet
GB201420311D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Pharmaceutical processing

Also Published As

Publication number Publication date
GB201420306D0 (en) 2014-12-31
RU2717574C2 (ru) 2020-03-24
MX2017006168A (es) 2017-09-12
RU2017116588A (ru) 2018-12-14
BR112017010070A2 (pt) 2018-01-02
CA2967738A1 (en) 2016-05-19
AU2015344838A1 (en) 2017-06-01
WO2016075495A1 (en) 2016-05-19
HUE047581T2 (hu) 2020-05-28
US20170333355A1 (en) 2017-11-23
PT3217964T (pt) 2019-11-26
CN106999438A (zh) 2017-08-01
JP2017534688A (ja) 2017-11-24
PL3217964T3 (pl) 2020-03-31
EP3217964B1 (en) 2019-09-04
RU2017116588A3 (zh) 2019-06-18
JP6774103B2 (ja) 2020-10-21
ES2755960T3 (es) 2020-04-24
SI3217964T1 (sl) 2020-02-28
US10675247B2 (en) 2020-06-09
EP3217964A1 (en) 2017-09-20
AU2015344838B2 (en) 2020-10-08
CA2967738C (en) 2021-07-06
KR20170084282A (ko) 2017-07-19
DK3217964T3 (da) 2019-11-25
KR102253728B1 (ko) 2021-05-21
SA517381522B1 (ar) 2021-04-06

Similar Documents

Publication Publication Date Title
HK1214967A1 (zh) 組合物
SG11201704735WA (en) Composition
HK1218859A1 (zh) 組合物
IL251479B (en) components
GB201408167D0 (en) Compositions
GB201403017D0 (en) Composition
HK1244432A1 (zh) 組合物
GB201414910D0 (en) Composition
ZA201704464B (en) Composition
GB201403561D0 (en) Composition
GB201414555D0 (en) Composition
GB201410493D0 (en) Composition
GB201519442D0 (en) Composition
ZA201606127B (en) Composition
GB201420628D0 (en) Composition
GB201415483D0 (en) Composition
GB201404390D0 (en) Composition
GB201402648D0 (en) Composition
SG11201610547WA (en) Solid composition
GB201404700D0 (en) Novel Composition
IL250781A0 (en) preparation
GB201503484D0 (en) Composition
GB201502355D0 (en) Composition
GB201421660D0 (en) Composition
GB201412414D0 (en) Composition